CRM
BRKR icon

Cramer Rosenthal McGlynn’s Bruker BRKR Stock Holding History

Cramer Rosenthal McGlynn’s Portfolio BRKR Stock Details BRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-773,458
Closed -$14.3M – 224
2015
Q1 		$14.3M Sell
773,458
-196,375
-20% -$3.72M 0.16% 158
2014
Q4 		$19M Sell
969,833
-68,550
-7% -$1.32M 0.2% 128
2014
Q3 		$19.2M Sell
1,038,383
-306,567
-23% -$6.55M 0.19% 129
2014
Q2 		$32.6M Buy
1,344,950
+14,075
+1% +$305K 0.26% 115
2014
Q1 		$30.3M Buy
1,330,875
+20,475
+2% +$447K 0.23% 124
2013
Q4 		$25.9M Buy
1,310,400
+396,225
+43% +$7.77M 0.19% 132
2013
Q3 		$18.9M Buy
+914,175
New +$17.5M 0.14% 152

Other funds holding BRKR

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Cramer Rosenthal McGlynn's BRKR Position: Q2 2015 in Review

Cramer Rosenthal McGlynn sold out of Bruker (BRKR) in Q2 2015, closing a stake of 773,458 shares — an estimated $14.3M sold.

Cramer Rosenthal McGlynn first reported a position in BRKR in Q3 2013 and held it in 7 quarters. The position peaked at $32.6M in Q2 2014. 159 funds tracked by Wall St. Rank hold BRKR as of Q2 2015.

  • Cramer Rosenthal McGlynn reported no remaining Bruker position as of Q2 2015 after selling out during the quarter.
  • Cramer Rosenthal McGlynn sold 773,458 Bruker shares in Q2 2015, an estimated $14.3M.
  • Cramer Rosenthal McGlynn first reported a position in Bruker in Q3 2013 and held it in 7 quarters.
  • Cramer Rosenthal McGlynn's Bruker position peaked at $32.6M in Q2 2014.
  • 159 funds tracked by Wall St. Rank held Bruker as of Q2 2015.

Based on Cramer Rosenthal McGlynn's 13F filing for Q2 2015, filed 14 Aug 2015.